NCT05753306View on ClinicalTrials.gov

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

March 25, 2026

Study Completion Date

March 31, 2028

Conditions
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaMetastatic Malignant Neoplasm in the Peritoneum
Interventions
DRUG

Cisplatin

Given via HIPEC

PROCEDURE

Computed Tomography

Undergo CT scan or PET/CT

PROCEDURE

Gastrectomy

Undergo robotic gastrectomy

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Positron Emission Tomography

Undergo PE/CT

OTHER

Questionnaire Administration

Complete questionnaire

DRUG

Paclitaxel

Given via HIPEC

DRUG

Hyperthermic Intraperitoneal Chemotherapy

Undergo HIPEC

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05753306 - Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study | Biotech Hunter | Biotech Hunter